+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Anti-Alzheimer's disease

Anti-Alzheimer's Disease refers to a broad spectrum of strategies, interventions, and treatments aimed at preventing, delaying the onset of, or managing the progression of Alzheimer's disease. This encompasses pharmacological agents, lifestyle modifications, cognitive training, and emerging therapies designed to mitigate neurodegeneration, improve cognitive function, and enhance quality of life for affected individuals.
Catalog No Product Description CAS No. Purity Structural Formula
BP3986 89505-76-0 98% Lycoramine Hydrobromide
BP0496
Dihydrolycorine
Dihydrolycorine is an inhibitors of protein synthesis in eukarytic cells, it halts protein synthesis in eukaryotic cells by inhibiting the peptide bone formation step. It protects against anoxia damage of brain in rat.Dihydrolycorine-HCL shows hypotensive effects, it can block alpha 1-adrenoceptors.
6271-21-2 98% Dihydrolycorine
BP4897
Isomitraphylline
Isomitraphylline and pteropodine are the most suitable for standardization of medical cat's claw preparations. Isomitraphylline can inhibit proliferation of acute lymphoblastic leukaemia cells.
4963-01-3 98% Isomitraphylline